Internal Medicine, Hematology & Oncology · Alabaster, AL
NPI
1134384787
Since 2008
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
3
Medicare group memberships
Hospitals
2
Hospital affiliations
1024 1st St N
Alabaster, AL, 35007
Phone (205) 664-4051
Groups this clinician bills Medicare through
Medicare paid, 2024
$74K
1,317 services
Medicare patients, 2024
521
Average age 73
Drug cost, 2024
$8.1M
2,886 prescriptions
Company payments, 2025
$1,989
From 36 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by James W Evans was code 99214 (office e&m - established), 507 times for 180 patients. In total James W Evans billed 1,317 services in 18 codes, and Medicare paid $74K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-10-18.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 507 | 180 | $64.46 | $33K |
| 99213 Office E&M - Established | Facility | 477 | 326 | $40.81 | $19K |
| 99232 Hospital E&M - Subsequent | Facility | 112 | 56 | $52.07 | $5,832 |
| 99223 Hospital E&M - Initial | Facility | 77 | 72 | $122.70 | $9,448 |
| 99205 Office E&M - New | Facility | 26 | 26 | $117.06 | $3,044 |
| 99204 Office E&M - New | Facility | 25 | 25 | $81.48 | $2,037 |
By year: 2022 $77K for 1,136 services; 2023 $71K for 1,132 services; 2024 $74K for 1,317 services.
Medicare prescription drug claims, 2024
In 2024, the drug James W Evans prescribed most often to Medicare patients was Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen), with 252 prescriptions and refills. In total James W Evans wrote 2,886 Medicare prescriptions that cost $8.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 252 | 252 | 69 | $5,030 |
| Ondansetron Hcl Generic | 165 | 165 | 88 | $1,760 |
| Letrozole Generic | 164 | 405 | 46 | $3,129 |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 133 | 133 | 23 | $4,316 |
| Xtandi Enzalutamide | 128 | 128 | 16 | $1.8M |
| Gabapentin Generic | 103 | 146 | 27 | $1,226 |
| Prochlorperazine Maleate Generic | 102 | 102 | 66 | $1,218 |
| Dexamethasone Generic | 100 | 103 | 32 | $1,699 |
| Oxycodone Hcl Generic | 94 | 94 | 19 | $1,513 |
| Acyclovir Generic | 81 | 97 | 19 | $1,045 |
| Hydroxyurea Generic | 78 | 127 | 23 | $1,905 |
| Zolpidem Tartrate Generic | 69 | 69 | 12 | $172 |
| Morphine Sulfate Er Morphine Sulfate | 68 | 68 | 18 | $2,387 |
| Eliquis Apixaban | 53 | 59 | Under 11 | $35K |
| Brukinsa Zanubrutinib | 53 | 53 | Under 11 | $729K |
Brand drugs: - claims; generic drugs: 2,271 claims; opioid claims: 643.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid James W Evans $1,989 ($1,989 in general payments such as food, travel and fees) from 36 companies. The largest payer was Novartis Pharmaceuticals Corporation with $213.
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation NVS | 10 | $213 |
| Pfizer Inc. PFE | 13 | $182 |
| Daiichi Sankyo Inc. 4568.T | 6 | $170 |
| AstraZeneca Pharmaceuticals LP AZN | 8 | $165 |
| E.R. Squibb & Sons, L.L.C. BMY | 6 | $103 |
| SpringWorks Therapeutics, Inc. | 4 | $93.24 |
| Merck Sharp & Dohme LLC MRK | 4 | $85.59 |
| Abbvie Inc. ABBV | 4 | $83.28 |
| Gilead Sciences, Inc. GILD | 3 | $68.17 |
| Novocure Inc. NVCR | 3 | $65.65 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.